Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

New York Times gets slammed for highlighting fact that Israel Defense Forces kills people

A New York Times article published Thursday about the Israel Defense Forces and Israeli military contractors’ efforts to devise a cure for the novel coronavirus attracted criticism on social media for pointing out that many of their prior developments had deadly capabilities.

“The Israeli Defense Ministry’s research-and-development arm is best known for pioneering cutting-edge ways to kill people and blow things up, with stealth tanks and sniper drones among its more lethal recent projects,” the article began. The quote was also used by the Times’ Twitter account to promote the article, which led to outrage from some pro-Israel advocates.

“What a vile @nytimes statement! And on 75th anniv. of end of WW2 & Holocaust, no less,” wrote American Jewish Committee CEO David Harris. “Should read: Israeli Defense Ministry’s research-and-development arm is best known for pioneering cutting-edge ways to defend #Israel since 1948 from annihilation by state/non-state actors.”

“Disappointed in the @nytimes for their shameful twisting of reality,” added Almog Elijis, the spokeswoman for Israel’s consulate in New York. “Saving lives is at the core of what Israel stands for, has always stood for, and will always stand for.”

But some current and former Israeli defense officials pointed out that the article, which went into detail about the various ways Israel’s military-industrial complex is fighting COVID, had a more nuanced view of the situation than its lead sentence indicated. Former IDF spokesperson Peter Lerner said it was a “great story” marred by its opening. David Halbfinger, the Times’ Jerusalem bureau chief, responded by arguing that pointing out the IDF’s mission to eliminate threats was not inherently a criticism.

The Times has been criticized for decades for allegedly being biased against Israel, and also for allegedly being biased against the Palestinians.

Aiden Pink is the deputy news editor of the Forward. Contact him at pink@forward.com or follow him on Twitter @aidenpink

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version